How is the FibroBiologics Inc today?

The FibroBiologics Inc today is trading in the down by -2.15% at 0.91.

How has FibroBiologics Inc performed historically?

The FibroBiologics Inc is currently trading down -2.15% on an intraday basis in the past week the index rose 4.60%. The index has been down -20.87% in the past quarter and fell -91.98% in the past year. You can view this in the overview section.

What is FibroBiologics Inc Annual Net Profit?

FibroBiologics Inc Annual Net Profit rose 32.3% in the last year to $11.16 M. Its sector's average net profit growth for the last fiscal year was -11.05%.

What is FibroBiologics Inc Price to Earning Ratio?

FibroBiologics Inc Price to Earning Ratio is -3.12, which is negative.

What is FibroBiologics Inc Stock Price?

FibroBiologics Inc Stock Price fell 91.98% and underperformed its sector by 100.38% in the past year.

What is FibroBiologics Inc Quarterly Net profit?

FibroBiologics Inc Quarterly Net profit rose 68.11% YoY to $3.1 M. Its sector's average net profit growth YoY for the quarter was -213.96%.

What is FibroBiologics Inc Debt to Equity Ratio?

FibroBiologics Inc Debt to Equity Ratio of 3.86 is higher than 1. This implies that company assets are financed through debt.

What is FibroBiologics Inc Return on Equity(ROE)?

FibroBiologics Inc Return on Equity(ROE) for the last financial year was -559.73%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is FibroBiologics Inc Mutual Fund Holding?

FibroBiologics Inc Mutual Fund Holding decreased by 1.13% in the last quarter to 11.83.

What is FibroBiologics Inc Interest Coverage Ratio?

FibroBiologics Inc Interest Coverage Ratio is -557.05, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is FibroBiologics Inc Institutional Holding?

FibroBiologics Inc Institutional Holding increased by 1.21% in the last quarter to 16.

FibroBiologics Inc XNAS: FBLG

FibroBiologics Inc Live Share Price Today, Share Analysis and Chart

Name: FibroBiologics Inc: Is Infosys Ltd. worth buying?
Item: FibroBiologics Inc
Rating: 0.46833325
Author: Trendlyne DVM scores

about

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple scle...

0.91 -0.02 (-2.15%)

93.30% Fall from 52W High

64,674 XNAS Volume

XNAS 19 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for FibroBiologics Inc is on 30 May 2025 for the purpose of FibroBiologics Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

1.3 / 100

Technically Bearish

17.4 / 100

No estimates available

FibroBiologics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

FibroBiologics Inc Live Share Price Today, Share Analysis and Chart

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple scle...

93.30% Fall from 52W High

SWOT Analysis

FibroBiologics Inc Live Price Chart

FibroBiologics Inc FAQ

How is FibroBiologics Inc today?

FibroBiologics Inc today is trading in the red, and is down by -2.15% at 0.91.

How has FibroBiologics Inc performed historically?

FibroBiologics Inc is currently trading down -2.15% on an intraday basis. In the past week the stock rose 4.60%. stock has been down -20.87% in the past quarter and fell -91.98% in the past year. You can view this in the overview section.